{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:41:07Z","timestamp":1655710867882},"reference-count":24,"publisher":"The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Med Sci"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3906\/sag-1502-65","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T12:25:56Z","timestamp":1461068756000},"page":"764-768","source":"Crossref","is-referenced-by-count":0,"title":["Intravitreal bevacizumab for retinopathy of prematurity in infants ineligible for laser therapy*"],"prefix":"10.55730","volume":"46","author":[{"given":"Ahmet Murad","family":"HONDUR","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet \u00d6zg\u00fcr","family":"\u00c7UBUK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z\u00fchal","family":"\u00d6ZEN TUNAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice Tuba","family":"ATALAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zdemir","family":"\u00d6ZDEM\u0130R","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130kbal Seza","family":"PETR\u0130\u00c7L\u0130","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130hsan G\u00f6khan","family":"G\u00dcREL\u0130K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"34691","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2584"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.12.023"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318177f934"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.140657"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318159ec6b"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181ca1457"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.04.018"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.01.014"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12124"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318275394a"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-014-0310-z"},{"key":"ref13","unstructured":"13. Bancalari MA, Schade YR, Pe\ufffda ZR, Pavez PN. Intravitreal bevacizumab as single drug therapy for retinopathy of prematurity in 12 patients. Arch Argent Pediatr 2014; 112: 160-163."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12339"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2011.07.017"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.07.028"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.2772"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. AMA Arch Ophthalmol 2003; 121: 1684-1696.","DOI":"10.1001\/archopht.121.12.1684"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. AMA Arch Ophthalmol 2005; 123: 991-999.","DOI":"10.1001\/archopht.123.7.991"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2012.592"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. de Klerk TA, Park DY, Biswas S. Prolonged follow-up period following intravitreal bevacizumab injection for stage 3+ retinopathy of prematurity. Eye (Lond) 2013; 27: 1218.","DOI":"10.1038\/eye.2013.148"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2013.711"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2012.10.025"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)01015-6"}],"container-title":["TURKISH JOURNAL OF MEDICAL SCIENCES"],"original-title":[],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T07:16:53Z","timestamp":1655709413000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.tubitak.gov.tr\/medical\/vol46\/iss3\/26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3906\/sag-1502-65","relation":{},"ISSN":["1300-0144","1303-6165"],"issn-type":[{"value":"1300-0144","type":"print"},{"value":"1303-6165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}